Isabl

Winter 2020Active

Cancer tests based on whole genome and transcriptome data.

Save

Isabl

Winter 2020Active

Cancer tests based on whole genome and transcriptome data.

Save

Company details

Isabl has developed software that can analyze the entire genome of cancer patients.

Today, when people get cancer, they get a genetic test of their tumor that analyzes only a few possible mutations. With Isabl, you run the tumor through an Illumina sequencer and get the whole genome, then our software is able to analyze all the mutations.

Our breakthrough technology provides unprecedented clarity into tumor biology to aid treatment planning. This opens up opportunities for precision diagnostics, disease surveillance and biomarker discovery.

Location

New York City, NY, USA; New York, NY, USA; Remote

Founded

Unknown

Request the Isabl report.

Isabl has no report yet. Sign in with your email to request one.